Azoles vs terbinafine
Azole probably leads to lower clinical cure compared with terbinafine (moderate certainty).
- RR 0.82 [0.72, 0.95]15 studies · 2168 participantsModerate
Azole probably leads to lower clinical cure compared with terbinafine (moderate certainty).
Azole leads to higher clinical cure compared with placebo (high certainty).
Azole leads to higher mycological cure compared with placebo (high certainty).
Azole showed no clear difference in adverse events compared with placebo (moderate certainty).
Azole showed no clear difference in recurrence rate compared with placebo (low certainty).
The review found no eligible studies for this question.
Azole probably leads to lower mycological cure compared with terbinafine (moderate certainty).
Azole showed no clear difference in adverse events compared with terbinafine (moderate certainty).
Azole showed no clear difference in recurrence rate compared with terbinafine (low certainty).
The review found no eligible studies for this question.
It is very uncertain whether combination terbinafine plus azole changes clinical cure compared with terbinafine monotherapy (very low certainty).
It is very uncertain whether combination terbinafine plus azole changes mycological cure compared with terbinafine monotherapy (very low certainty).
Combination terbinafine plus azole showed no clear difference in adverse events compared with terbinafine monotherapy (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.